rethinkPeptides Search
Menu
Research citation

A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy.

Diabetes research and clinical practice, 217, 111871

Citation

Cheng, Alice Y Y; Mauricio, Didac; Ritzel, Robert; Al-Sofiani, Mohammed E; Bailey, Timothy; Aileen Mabunay, Maria; Bonnemaire, Mireille; Melas-Melt, Lydie; Mimouni, Safia; Davies, Melanie. (2024). A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy.. Diabetes research and clinical practice, 217, 111871. https://doi.org/10.1016/j.diabres.2024.111871